| UniProt ID | PGRC2_HUMAN | |
|---|---|---|
| UniProt AC | O15173 | |
| Protein Name | Membrane-associated progesterone receptor component 2 | |
| Gene Name | PGRMC2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 223 | |
| Subcellular Localization |
Membrane Single-pass membrane protein . |
|
| Protein Description | Receptor for steroids.. | |
| Protein Sequence | MAAGDGDVKLGTLGSGSESSNDGGSESPGDAGAAAEGGGWAAAALALLTGGGEMLLNVALVALVLLGAYRLWVRWGRRGLGAGAGAGEESPATSLPRMKKRDFSLEQLRQYDGSRNPRILLAVNGKVFDVTKGSKFYGPAGPYGIFAGRDASRGLATFCLDKDALRDEYDDLSDLNAVQMESVREWEMQFKEKYDYVGRLLKPGEEPSEYTDEEDTKDHNKQD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 90 | Phosphorylation | GAGAGEESPATSLPR CCCCCCCCCCCCCCC | 18.61 | 19664994 | |
| 93 | Phosphorylation | AGEESPATSLPRMKK CCCCCCCCCCCCHHH | 33.89 | 30266825 | |
| 94 | Phosphorylation | GEESPATSLPRMKKR CCCCCCCCCCCHHHC | 38.18 | 22167270 | |
| 100 | Malonylation | TSLPRMKKRDFSLEQ CCCCCHHHCCCCHHH | 48.10 | 26320211 | |
| 104 | Phosphorylation | RMKKRDFSLEQLRQY CHHHCCCCHHHHHHC | 34.97 | 23401153 | |
| 109 | Methylation | DFSLEQLRQYDGSRN CCCHHHHHHCCCCCC | 32.48 | 115487343 | |
| 114 | Phosphorylation | QLRQYDGSRNPRILL HHHHCCCCCCCEEEE | 26.45 | 19664994 | |
| 117 | Phosphorylation | QYDGSRNPRILLAVN HCCCCCCCEEEEEEC | 24.47 | - | |
| 118 | Phosphorylation | YDGSRNPRILLAVNG CCCCCCCEEEEEECC | 35.42 | - | |
| 124 | Ubiquitination | PRILLAVNGKVFDVT CEEEEEECCEEEEEC | 38.67 | - | |
| 126 | Acetylation | ILLAVNGKVFDVTKG EEEEECCEEEEECCC | 34.23 | 133447 | |
| 126 | Ubiquitination | ILLAVNGKVFDVTKG EEEEECCEEEEECCC | 34.23 | 21890473 | |
| 126 | 2-Hydroxyisobutyrylation | ILLAVNGKVFDVTKG EEEEECCEEEEECCC | 34.23 | - | |
| 128 | Phosphorylation | LAVNGKVFDVTKGSK EEECCEEEEECCCCC | 7.72 | 24719451 | |
| 132 | 2-Hydroxyisobutyrylation | GKVFDVTKGSKFYGP CEEEEECCCCCCCCC | 62.12 | - | |
| 132 | Ubiquitination | GKVFDVTKGSKFYGP CEEEEECCCCCCCCC | 62.12 | - | |
| 133 | Methylation | KVFDVTKGSKFYGPA EEEEECCCCCCCCCC | 27.05 | - | |
| 135 | 2-Hydroxyisobutyrylation | FDVTKGSKFYGPAGP EEECCCCCCCCCCCC | 51.80 | - | |
| 135 | Acetylation | FDVTKGSKFYGPAGP EEECCCCCCCCCCCC | 51.80 | 25953088 | |
| 135 | Ubiquitination | FDVTKGSKFYGPAGP EEECCCCCCCCCCCC | 51.80 | 21890473 | |
| 137 | Phosphorylation | VTKGSKFYGPAGPYG ECCCCCCCCCCCCCC | 26.41 | 28152594 | |
| 143 | Phosphorylation | FYGPAGPYGIFAGRD CCCCCCCCCEEECCC | 23.18 | 21253578 | |
| 149 | Methylation | PYGIFAGRDASRGLA CCCEEECCCCCCCCC | 32.65 | 115487335 | |
| 150 | Ubiquitination | YGIFAGRDASRGLAT CCEEECCCCCCCCCH | 48.23 | 21890473 | |
| 156 | Ubiquitination | RDASRGLATFCLDKD CCCCCCCCHHHCCHH | 11.06 | 23000965 | |
| 159 | Ubiquitination | SRGLATFCLDKDALR CCCCCHHHCCHHHHH | 4.11 | 21890473 | |
| 159 | Glutathionylation | SRGLATFCLDKDALR CCCCCHHHCCHHHHH | 4.11 | 22555962 | |
| 162 | Acetylation | LATFCLDKDALRDEY CCHHHCCHHHHHHCC | 31.77 | 25825284 | |
| 162 | Ubiquitination | LATFCLDKDALRDEY CCHHHCCHHHHHHCC | 31.77 | - | |
| 166 | Methylation | CLDKDALRDEYDDLS HCCHHHHHHCCCCHH | 36.11 | 115487327 | |
| 167 | Phosphorylation | LDKDALRDEYDDLSD CCHHHHHHCCCCHHH | 60.71 | - | |
| 169 | Phosphorylation | KDALRDEYDDLSDLN HHHHHHCCCCHHHCC | 21.03 | 27642862 | |
| 173 | Methylation | RDEYDDLSDLNAVQM HHCCCCHHHCCCCHH | 47.23 | - | |
| 173 | Phosphorylation | RDEYDDLSDLNAVQM HHCCCCHHHCCCCHH | 47.23 | - | |
| 180 | Sulfoxidation | SDLNAVQMESVREWE HHCCCCHHHHHHHHH | 3.13 | 28465586 | |
| 186 | Acetylation | QMESVREWEMQFKEK HHHHHHHHHHHHHHH | 8.87 | - | |
| 186 | Ubiquitination | QMESVREWEMQFKEK HHHHHHHHHHHHHHH | 8.87 | 23000965 | |
| 190 | Methylation | VREWEMQFKEKYDYV HHHHHHHHHHHHCCH | 12.16 | - | |
| 191 | Ubiquitination | REWEMQFKEKYDYVG HHHHHHHHHHHCCHH | 36.08 | 21890473 | |
| 193 | Malonylation | WEMQFKEKYDYVGRL HHHHHHHHHCCHHCC | 43.97 | 26320211 | |
| 193 | Ubiquitination | WEMQFKEKYDYVGRL HHHHHHHHHCCHHCC | 43.97 | 21890473 | |
| 193 | Acetylation | WEMQFKEKYDYVGRL HHHHHHHHHCCHHCC | 43.97 | 23749302 | |
| 193 | Phosphorylation | WEMQFKEKYDYVGRL HHHHHHHHHCCHHCC | 43.97 | - | |
| 193 | 2-Hydroxyisobutyrylation | WEMQFKEKYDYVGRL HHHHHHHHHCCHHCC | 43.97 | - | |
| 194 | Phosphorylation | EMQFKEKYDYVGRLL HHHHHHHHCCHHCCC | 17.38 | 26074081 | |
| 196 | Phosphorylation | QFKEKYDYVGRLLKP HHHHHHCCHHCCCCC | 11.17 | 25884760 | |
| 197 | Phosphorylation | FKEKYDYVGRLLKPG HHHHHCCHHCCCCCC | 3.08 | - | |
| 208 | Phosphorylation | LKPGEEPSEYTDEED CCCCCCCCCCCCHHH | 46.65 | 29255136 | |
| 210 | Phosphorylation | PGEEPSEYTDEEDTK CCCCCCCCCCHHHCC | 24.67 | 23927012 | |
| 211 | Phosphorylation | GEEPSEYTDEEDTKD CCCCCCCCCHHHCCC | 32.65 | 29255136 | |
| 215 | Ubiquitination | SEYTDEEDTKDHNKQ CCCCCHHHCCCCCCC | 57.94 | 21890473 | |
| 216 | Phosphorylation | EYTDEEDTKDHNKQD CCCCHHHCCCCCCCC | 41.47 | 29255136 | |
| 217 | Acetylation | YTDEEDTKDHNKQD- CCCHHHCCCCCCCC- | 70.12 | - | |
| 217 | Ubiquitination | YTDEEDTKDHNKQD- CCCHHHCCCCCCCC- | 70.12 | 21890473 | |
| 220 | Phosphorylation | EEDTKDHNKQD---- HHHCCCCCCCC---- | 54.54 | - | |
| 226 | Ubiquitination | HNKQD---------- CCCCC---------- | - | ||
| 232 | Phosphorylation | ---------------- ---------------- | 20166139 | ||
| 234 | Phosphorylation | ------------------ ------------------ | 20166139 | ||
| 235 | Phosphorylation | ------------------- ------------------- | 18452278 | ||
| 240 | Phosphorylation | ------------------------ ------------------------ | 20166139 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PGRC2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PGRC2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PGRC2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of PGRC2_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-208 AND TYR-210,AND MASS SPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208 AND THR-211, ANDMASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90 AND THR-211, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-210 AND THR-211, ANDMASS SPECTROMETRY. | |